+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Macular Degeneration"

Global Fundus Cameras Market Analysis 2026-2031 - Product Thumbnail Image

Global Fundus Cameras Market Analysis 2026-2031

  • Report
  • September 2026
  • 128 Pages
  • Global
From
Ophthalmic Optical Coherence Tomography Market Analysis - Product Thumbnail Image

Ophthalmic Optical Coherence Tomography Market Analysis

  • Report
  • September 2026
  • 139 Pages
  • Global
From
Orthokeratology Contact Lenses Market Analysis 2026-2031 - Product Thumbnail Image

Orthokeratology Contact Lenses Market Analysis 2026-2031

  • Report
  • September 2026
  • 127 Pages
  • Global
From
From
From
From
From
From
Age Related Macular Degeneration - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Age Related Macular Degeneration - Global Clinical Trials Review, 2026

  • Clinical Trials
  • August 2026
  • 1100 Pages
  • Global
From
From
From
From
From
Electroretinogram Market in the United States - Product Thumbnail Image

Electroretinogram Market in the United States

  • Report
  • March 2026
  • 250 Pages
  • United States
From
Loading Indicator

Macular Degeneration is a condition that affects the central part of the retina, known as the macula, which is responsible for sharp, central vision. It is the leading cause of vision loss in people over the age of 50. Optical treatments for Macular Degeneration include laser photocoagulation, photodynamic therapy, and anti-VEGF injections. Laser photocoagulation is used to reduce the risk of further vision loss by sealing off leaking blood vessels in the macula. Photodynamic therapy is used to reduce the growth of abnormal blood vessels in the macula. Anti-VEGF injections are used to reduce the growth of abnormal blood vessels and improve vision. Companies in the Macular Degeneration market include Novartis, Regeneron, Allergan, Genentech, and Roche. Show Less Read more